Cancer metastasis and therapy resistance are the major unsolved clinical challenges, and
account for nearly all cancer-related deaths. Both metastasis and therapy resistance are …

It is currently hoped that deaths from extra‐uterine high‐grade serous cancer (HGSC) will be
reduced via opportunistic salpingectomy in healthy women. Accumulated data implicate the …

Epithelial–mesenchymal transition (EMT) has an established role in promoting tumor
progression and the acquisition of therapeutic resistance. Here, the EMT phenotype was …

Background The link between prostate cancer (PCa) development and aberrant expression
of genes located on the Y chromosome remains unclear. Objective To identify Y …

Background Metastasis, the leading cause of cancer-related death in patients diagnosed
with ovarian cancer (OC), is a complex process that involves multiple biological effects. With …

Ovarian cancer is the most lethal gynecologic malignancy, and transcoelomic metastasis is
responsible for the greatest disease mortality. Although intensive efforts have been made …

Given the difficulties inherent in maintaining human pluripotent stem cells (hPSCs) in a
healthy state, hPSCs should be routinely characterized using several established standard …

Objective Ovarian cancer has the highest mortality rate among gynecological malignant
tumors, and it preferentially metastasizes to omental tissue, leading to intestinal obstruction …

This study aims to investigate applicable robust biomarkers that can improve prognostic
predictions for colorectal liver metastasis (CRLM) patients receiving simultaneous resection …

During tumor progression, epithelial ovarian cancer (EOC) cells undergo epithelial-to-
mesenchymal transition (EMT), which influences metastatic success. Mutation-dependent …